Cargando…
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
Pediatric patients with high-risk neuroblastoma often relapse with chemotherapy-resistant, incurable disease. Relapsed neuroblastomas harbor chemo-resistant mesenchymal tumor cells and increased expression/activity of the transcriptional co-regulator, the Yes-Associated Protein (YAP). Patients with...
Autores principales: | Pilgrim, Adeiye A., Jonus, Hunter C., Ho, Andrew, Cole, Anna C., Shim, Jenny, Goldsmith, Kelly C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405770/ https://www.ncbi.nlm.nih.gov/pubmed/37554309 http://dx.doi.org/10.1080/2162402X.2023.2240678 |
Ejemplares similares
-
Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials
por: Jonus, Hunter C., et al.
Publicado: (2022) -
A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
por: Shim, Jenny, et al.
Publicado: (2021) -
Role of GD3 Synthase ST8Sia I in Cancers
por: Kasprowicz, Angelina, et al.
Publicado: (2022) -
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023) -
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
por: Mabe, Nathaniel W., et al.
Publicado: (2022)